US Stock MarketDetailed Quotes

VOR Vor Biopharma

Watchlist
  • 0.834
  • -0.026-3.01%
Close Nov 7 16:00 ET
  • 0.800
  • -0.034-4.09%
Post 19:57 ET
57.05MMarket Cap-482P/E (TTM)

Vor Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-9.76%29.04M
6.26%32.33M
34.92%126.04M
13.75%28.12M
46.53%35.32M
47.64%32.17M
33.43%30.42M
35.35%93.42M
35.07%24.73M
29.56%24.1M
Selling and administrative expenses
-12.87%7.21M
-5.91%8M
9.88%31.72M
-5.69%7.23M
6.70%7.71M
28.15%8.28M
13.13%8.51M
34.34%28.87M
36.52%7.66M
27.29%7.23M
-General and administrative expense
-12.87%7.21M
-5.91%8M
9.88%31.72M
-5.69%7.23M
6.70%7.71M
28.15%8.28M
13.13%8.51M
34.34%28.87M
36.52%7.66M
27.29%7.23M
Research and development costs
-8.68%21.82M
10.98%24.32M
46.11%94.32M
22.48%20.9M
63.59%27.61M
55.85%23.9M
43.42%21.92M
35.81%64.55M
34.42%17.06M
30.56%16.88M
Operating profit
9.76%-29.04M
-6.26%-32.33M
-34.92%-126.04M
-13.75%-28.12M
-46.53%-35.32M
-47.64%-32.17M
-33.43%-30.42M
-35.35%-93.42M
-35.07%-24.73M
-29.56%-24.1M
Net non-operating interest income expense
-45.51%1.2M
-23.48%1.52M
517.30%8.17M
128.59%1.86M
579.23%2.13M
1,550.38%2.2M
3,057.14%1.99M
1,012.61%1.32M
1,409.26%815K
552.08%313K
Non-operating interest income
-45.51%1.2M
-23.48%1.52M
517.30%8.17M
128.59%1.86M
579.23%2.13M
1,550.38%2.2M
3,057.14%1.99M
1,012.61%1.32M
1,409.26%815K
552.08%313K
Other net income (expense)
Income before tax
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-33.67%-92.09M
-31.00%-23.91M
-28.21%-23.79M
Income tax
Net income
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-33.67%-92.09M
-31.00%-23.91M
-28.21%-23.79M
Net income continuous Operations
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-33.67%-92.09M
-31.00%-23.91M
-28.21%-23.79M
Minority interest income
Net income attributable to the parent company
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-33.67%-92.09M
-31.00%-23.91M
-28.21%-23.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-31.32%-92.09M
-31.00%-23.91M
-28.21%-23.79M
Basic earnings per share
8.89%-0.41
-4.65%-0.45
24.89%-1.75
26.92%-0.38
22.22%-0.49
22.41%-0.45
29.51%-0.43
-10.95%-2.33
-8.33%-0.52
-26.00%-0.63
Diluted earnings per share
8.89%-0.41
-4.65%-0.45
24.89%-1.75
26.92%-0.38
22.22%-0.49
22.41%-0.45
29.51%-0.43
-10.95%-2.33
-8.33%-0.52
-26.00%-0.63
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -9.76%29.04M6.26%32.33M34.92%126.04M13.75%28.12M46.53%35.32M47.64%32.17M33.43%30.42M35.35%93.42M35.07%24.73M29.56%24.1M
Selling and administrative expenses -12.87%7.21M-5.91%8M9.88%31.72M-5.69%7.23M6.70%7.71M28.15%8.28M13.13%8.51M34.34%28.87M36.52%7.66M27.29%7.23M
-General and administrative expense -12.87%7.21M-5.91%8M9.88%31.72M-5.69%7.23M6.70%7.71M28.15%8.28M13.13%8.51M34.34%28.87M36.52%7.66M27.29%7.23M
Research and development costs -8.68%21.82M10.98%24.32M46.11%94.32M22.48%20.9M63.59%27.61M55.85%23.9M43.42%21.92M35.81%64.55M34.42%17.06M30.56%16.88M
Operating profit 9.76%-29.04M-6.26%-32.33M-34.92%-126.04M-13.75%-28.12M-46.53%-35.32M-47.64%-32.17M-33.43%-30.42M-35.35%-93.42M-35.07%-24.73M-29.56%-24.1M
Net non-operating interest income expense -45.51%1.2M-23.48%1.52M517.30%8.17M128.59%1.86M579.23%2.13M1,550.38%2.2M3,057.14%1.99M1,012.61%1.32M1,409.26%815K552.08%313K
Non-operating interest income -45.51%1.2M-23.48%1.52M517.30%8.17M128.59%1.86M579.23%2.13M1,550.38%2.2M3,057.14%1.99M1,012.61%1.32M1,409.26%815K552.08%313K
Other net income (expense)
Income before tax 7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-33.67%-92.09M-31.00%-23.91M-28.21%-23.79M
Income tax
Net income 7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-33.67%-92.09M-31.00%-23.91M-28.21%-23.79M
Net income continuous Operations 7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-33.67%-92.09M-31.00%-23.91M-28.21%-23.79M
Minority interest income
Net income attributable to the parent company 7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-33.67%-92.09M-31.00%-23.91M-28.21%-23.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-31.32%-92.09M-31.00%-23.91M-28.21%-23.79M
Basic earnings per share 8.89%-0.41-4.65%-0.4524.89%-1.7526.92%-0.3822.22%-0.4922.41%-0.4529.51%-0.43-10.95%-2.33-8.33%-0.52-26.00%-0.63
Diluted earnings per share 8.89%-0.41-4.65%-0.4524.89%-1.7526.92%-0.3822.22%-0.4922.41%-0.4529.51%-0.43-10.95%-2.33-8.33%-0.52-26.00%-0.63
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.65%